DB02137ExperimentalSmall molecule
Absence of molybdenum cofactor leads to accumulation of toxic levels of sulphite and neurological damage usually leading to death within months of birth, due to the lack of active sulfite...
- Formula / weight
- C10H10MoN5O8PS2 · 519.26 g/mol (avg)
Resolves to
Structure
InChIKey
HDAJUGGARUFROU-JSUDGWJLSA-JSMILESO=[Mo++]=O.NC1=NC2=C(N[C@@H]3[C@H](N2)O[C@H](COP([O-])([O-])=O)C([S-])=C3[S-])C(=O)N1Targets
What you can answer from here — as of August 31, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with Molybdenum cofactor, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account